The primary objective of our Belgian working group is to collect evidence for creating a practical recommendation for systemic treatment of patients with psoriasis (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis) to advise HCPs on what treatment is prescribed for which patient.

The outcome is primarily focused as a perspective for Belgian Dermatologists (as no psoriasis guideline is currently available in Belgium) to optimally treat psoriasis patients with predisposing and concomitant conditions or comorbidities.

For more information and links to publications by the BETA-pso working group, please visit the KBVDV website.